Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11018599 | HPB | 2018 | 11 Pages |
Abstract
LT offered the lowest rate of cancer recurrence and highest chance of long-term survival. Differences in outcome likely reflect a combination of cancer-related factors (AFP, micro- and macrovascular invasion), patient-related factors (performance status, co-morbidities and psychosocial issues) and treatment type. Two thirds of patients treated by LR and three quarters treated by TA had HCC recurrence by 5 years, reinforcing the need for close long-term surveillance.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Lily Wu, Peter Swan, John McCall, Edward Gane, Andrew Holden, Stephen Merrilees, Stephen Munn, Peter Johnston, Adam Bartlett,